Bone Biologics Corp (BBLG) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Total interest expense							-1.9	-1.4
Net interest income							-1.9	-1.4
Pre-tax income before non-recurring items	-1.6	-1.8	-3.4	-4.4	-7.0	-25.9	-13.9	-4.4
Non-recurring items						0.0
Pre-tax income	-1.6	-1.8	-3.4	-4.4	-7.0	-25.9	-13.9	-4.4
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate
Net income	-1.6	-1.8	-3.4	-4.4	-7.1	-25.9	-13.9	-4.4
Net margin							741.3%	315.4%

Basic EPS	($0.35)	($0.63)	($0.47)	($0.88)	($1.81)	($0.69)	($0.49)	($0.30)
Diluted EPS	($0.35)	($0.63)	($0.47)	($0.88)	($1.81)	($0.69)	($0.49)	($0.30)

Shares outstanding (basic)	4.5	2.9	7.3	5.0	3.9	37.6	28.5	15.0
Shares outstanding (diluted)	4.5	2.9	7.3	5.0	3.9	37.6	28.5	15.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.